Financial Advocates Investment Management Inmune Bio, Inc. Transaction History
Financial Advocates Investment Management
- $1.78 Billion
- Q3 2024
A detailed history of Financial Advocates Investment Management transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Financial Advocates Investment Management holds 13,500 shares of INMB stock, worth $66,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,500
Previous 11,500
17.39%
Holding current value
$66,960
Previous $101,000
28.71%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding INMB
# of Institutions
70Shares Held
5.88MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$4.03 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$3.87 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA721KShares$3.57 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$2.96 Million45.87% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$1.83 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $89M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...